Chlorthalidone Dosing and Monitoring Guidelines

Initial Dosing and Monitoring

The American College of Cardiology recommends initiating chlorthalidone at 25 mg once daily in the morning with food for most adults with hypertension, and monitoring serum sodium, potassium, and creatinine within 2-4 weeks of initiation or any dose change 1, 2, 3
Doses above 50 mg provide minimal additional benefit due to a flat dose-response curve but substantially increase adverse effects including hyponatremia, as reported by the Hypertension journal 4

Chlorthalidone carries a 3-fold higher risk of hyponatremia compared to hydrochlorothiazide due to its prolonged 24-72 hour duration of action, according to Circulation 6
Hold chlorthalidone if serum sodium drops below 130 mEq/L, as recommended by Praxis Medical Insights 5

Monitor serum potassium, holding if <3.5 mEq/L, as recommended by Hypertension and Praxis Medical Insights 4, 5
Monitor serum creatinine and eGFR, holding if acute kidney injury develops or azotemia worsens, as recommended by Praxis Medical Insights 5
Use caution in patients with gout history unless on uric acid-lowering therapy, as recommended by the American College of Cardiology and Hypertension 1, 3

In pediatric patients, the initial dose is 0.3 mg/kg/day once daily, with a maximum of 2 mg/kg/day up to 50 mg/day, requiring particularly vigilant electrolyte monitoring, as recommended by Praxis Medical Insights 2
Use chlorthalidone with extreme caution in severe renal impairment, as it may precipitate azotemia, as recommended by Praxis Medical Insights 2, 5

For stage 1 hypertension with 10-year ASCVD risk ≥10%, repeat BP evaluation in 1 month, as recommended by the Journal of the American College of Cardiology and Praxis Medical Insights 3, 5
For stage 2 hypertension, evaluate within 1 month, often requiring combination therapy with a second agent from a different class, as recommended by the Journal of the American College of Cardiology and Praxis Medical Insights 3, 5